概念文章:抗抑郁药诱导的双极性疾病中的不稳定,由血清素3受体 (5HT3) 介导
Irem Hacisalihoglu Aydin1, Rif S El-Mallakh1
1Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Bipolar disorders
|September 1, 2024
概括
抗抑郁药可以通过增加细胞内水平,特别是通过血清素5HT3受体,使双极性障碍恶化. 阻止这些受体可能为双极性抑郁症提供一种新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗抑郁药可以使双相情感障碍患者不稳定,增加躁狂,抑郁和骑自行车.
- 目前关于抗抑郁药"超越"的理论不太可能,因为抗抑郁药对双极性抑郁症无效.
研究的目的:
- 探索双相情绪障碍的病理生理学,专注于细胞内和血清素5HT3受体.
- 提出一种新的机制,用于抗抑郁药诱导的双相情感障碍的不稳定.
主要方法:
- 使用PubMed的文献搜索,使用关键词:"双极"","",细胞内"",血清素3"",5HT3"",5-二胺3型受体"和"抗抑郁药".
- 对细胞内和血清素受体在双相情感障碍中的作用进行现有研究的分析.
主要成果:
- 细胞内 (Na) 的升高与双相情绪障碍中的情绪状态有关,影响神经元刺激性.
- 血清素5HT3受体刺激直接使神经元脱极化,可能恶化躁狂和抑郁症.
- 抗抑郁药物治疗可能会通过激活5HT3受体加剧细胞内的升高.
结论:
- 纳活动的下降导致细胞内纳增加,这是双相情感障碍的一个关键异常.
- 通过5HT3激活,抗抑郁药对这种效应的强化提供了一个可测试的假设.
- 与抗抑郁药物同时使用5HT3抗剂可能是治疗双极性抑郁症的可行策略.
相关概念视频
G-protein Coupled Receptors
92.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
92.3K
Mania and Antimanic Drugs: Overview
808
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
808
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K


